Skip to content
Homepage
Author:
Hemogenyx Pharmaceuticals PLC
Posted Date:
June 5, 2026
Hemogenyx Pharmaceuticals PLC Announces Notice of AGM
Hemogenyx Pharmaceuticals PLC
June 5, 2026
Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term
Hemogenyx Pharmaceuticals PLC
May 29, 2026
Hemogenyx Pharmaceuticals PLC Announces Final Results
Hemogenyx Pharmaceuticals PLC
April 30, 2026
Hemogenyx Pharmaceuticals PLC Announces Institutional Fundraise
Hemogenyx Pharmaceuticals PLC
April 28, 2026
Hemogenyx Pharmaceuticals PLC Announces Annual IND Report with FDA
Hemogenyx Pharmaceuticals PLC
April 14, 2026
Hemogenyx Pharmaceuticals PLC Announces Tech Transfer Completion and Clinical Trial Update
Hemogenyx Pharmaceuticals PLC
March 31, 2026
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
Hemogenyx Pharmaceuticals PLC
February 27, 2026
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Hemogenyx Pharmaceuticals PLC
February 23, 2026
CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
Hemogenyx Pharmaceuticals PLC
February 10, 2026
Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
Hemogenyx Pharmaceuticals PLC
February 10, 2026
